All Press Releases for August 16, 2023

Clark Springgate, MD, Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's Who

Dr. Clark Springgate has been endorsed by Marquis Who's Who as a leader in oncology and immunology



Dr. Springgate is the vice president and chief medical officer at Springgate Biotechnology Consultants.

    GUILFORD, CT, August 16, 2023 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to present Clark Springgate, MD, with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Dr. Springgate celebrates many years' experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Dr. Springgate is the vice president and chief medical officer at Springgate Biotechnology Consultants. Launching his private practice in Guilford, Connecticut, in 2003, his company specializes in medical oncology, focusing on oncology clinical development and regulatory affairs. Dr. Springgate also co-founded a biotechnology company called Galectin Therapeutics, which concentrates on discovery and development. Moreover, he has spent over 35 years as a consultant physician providing second opinions.

Highly accomplished in oncology, immunology, and drug and biologics development, Dr. Springgate formerly served as the chief medical officer of oncology and immunology at Glycogenesys in Boston from 1999 to 2003. Spearheading numerous initiatives, including drug development strategy and FDA submissions, he also collaborated with the MD Anderson Cancer Center for several years regarding prostate cancer indication with patients that had previously failed standard treatment. Among other objectives, Dr. Springgate has conducted numerous clinical trials.

Among other noteworthy roles, Dr. Springgate was the vice president of clinical and regulatory affairs for CMO immunology and oncology for the National Medical Research Corporation in Hartford, Connecticut, and the chief medical officer of immunology and oncology for the Clinical Research Group in Englewood, New Jersey. During an earlier stage of his career, he was a medical director and attending physician for clinical immunology laboratories at the Ochsner Foundation Hospital and Clinic. Dr. Springgate also taught in the classroom as an assistant professor in the department of microbiology and immunology at Tulane Medical Center.

Dr. Springgate's extensive education includes a Bachelor of Arts in biology from Boston University, a Doctor of Philosophy in biochemistry at Boston College in 1972, and a Doctor of Medicine from the University of Miami in 1983. Additional educational pursuits to his credit include a residency and fellowship in clinical pathology at Tulane Medical Center. Dr. Springgate received a medical license in Connecticut and board certification in clinical pathology through the American Board of Pathology.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Marquis celebrates its 125th anniversary in 2023, and Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® publications may be visited at the official Marquis Who's Who® website at www.marquiswhoswho.com.

# # #

Contact Information

-- --
Marquis Who's Who Ventures LLC
Uniondale, NY
USA
Voice: 844-394-6946
E-Mail: Email Us Here
Website: Visit Our Website
Follow Us: